{
    "title": "Ozempic's early success in kidney disease trial drags down dialysis stocks",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12619125/Ozempics-early-success-kidney-disease-trial-hits-dialysis-stocks.html",
    "date": "2023-10-11",
    "keywords": [
        "dialysis",
        "success",
        "glp1",
        "news",
        "analyst",
        "utterback",
        "fresenius",
        "oct",
        "service",
        "wednesday",
        "progression",
        "kidney",
        "disease",
        "novos",
        "announcement",
        "sign",
        "disruption",
        "food",
        "surgery",
        "device",
        "treatment",
        "type",
        "loss",
        "baxter",
        "therapy",
        "drugmaker",
        "tuesday",
        "trial",
        "year",
        "schedule",
        "study",
        "preset",
        "efficacy",
        "data",
        "monitoring",
        "committee",
        "market",
        "obesity",
        "contribute",
        "damage",
        "ozempic",
        "wegovy",
        "julie",
        "transition",
        "term",
        "novo",
        "piece",
        "kidneydisease",
        "population",
        "medication",
        "ratio",
        "benchmark",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "janane",
        "venkatraman",
        "pooja",
        "desai",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}